Philippe L. Bedard

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Philippe L. Bedard

Feb 27, 2025, 11:45 | Blog

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…

Jan 24, 2025, 02:01 | Blog

Gustavo Viani: Can SBRT delay systemic therapy chances in oligoprogressive cancer?

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo, shared…

Sep 14, 2024, 00:00 | Insight

Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer

Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…

Jul 11, 2024, 10:49 | Insight

Alberto Hernando-Calvo: Durvalumab with Olaparib or Cediranib in patients with pMMR CRC or Pancreatic Cancer

Alberto Hernando-Calvo, Clinician scientist at Vall d'Hebron Barcelona Hospital, shared on X: "Phase II, open-label,…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023